Most of us have experienced anxiety or will at some point in the future. It's normal to feel worried from time to time.

St. Elizabeth Healthcare Is anxiety a mood disorder or is it a physical reaction to emotional stress? The answer is that it ...

Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...

Global Cannabis Use Disorder Treatment Market. The global cannabis use disorder treatment market is expected to grow from USD ...

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major ...

A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.

Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt ...

The Boston-based startup is developing what executives hope will be more effective treatments for depression, anxiety, and ...

AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric ...

AbbVie (ABBV) and Gedeon Richter announced a new discovery, co-development and license agreement to advance novel targets for the potential ...